Engineering proteases with altered specificity

Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in biotechnology 1994, Vol.5 (4), p.403-408
Hauptverfasser: Leis, Jonathan P, Cameron, Craig E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 408
container_issue 4
container_start_page 403
container_title Current opinion in biotechnology
container_volume 5
creator Leis, Jonathan P
Cameron, Craig E
description Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.
doi_str_mv 10.1016/0958-1669(94)90049-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16571753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0958166994900493</els_id><sourcerecordid>16571753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</originalsourceid><addsrcrecordid>eNp9kDtPwzAQxy0EKqXwDUDKhGBIOceveEFCVXlIlVhgthznUozSpNgpqN-ehFYdmW74P-7uR8glhSkFKu9AizylUuobzW81ANcpOyJjmiudAs_0MRkfLKfkLMZPABBMwYiMlJKCKjYm03mz9A1i8M0yWYe2QxsxJj---0hs3WHAMolrdL7yznfbc3JS2TrixX5OyPvj_G32nC5en15mD4vUMaa7FDNuyww4VkJJkErw3IHKuSh0UXB0nIqKodRlxquSV2h1hVpRh8yCEpCxCbne9fYnfW0wdmblo8O6tg22m2ioFIoqwXoj3xldaGMMWJl18CsbtoaCGTCZgYEZGBjNzR8mM8Su9v2bYoXlIbTn0uv3Ox37J789BhOdx8Zh6QO6zpSt_3_BL2kkdk0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16571753</pqid></control><display><type>article</type><title>Engineering proteases with altered specificity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Leis, Jonathan P ; Cameron, Craig E</creator><creatorcontrib>Leis, Jonathan P ; Cameron, Craig E</creatorcontrib><description>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</description><identifier>ISSN: 0958-1669</identifier><identifier>EISSN: 1879-0429</identifier><identifier>DOI: 10.1016/0958-1669(94)90049-3</identifier><identifier>PMID: 7765173</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aspartic Acid Endopeptidases - genetics ; Aspartic Acid Endopeptidases - metabolism ; Bacteria - enzymology ; human immunodeficiency virus 1 ; Models, Molecular ; Mutagenesis ; Protein Engineering ; Retroviridae - enzymology ; Rous sarcoma virus ; Serine Endopeptidases - genetics ; Serine Endopeptidases - metabolism ; Structure-Activity Relationship ; Substrate Specificity</subject><ispartof>Current opinion in biotechnology, 1994, Vol.5 (4), p.403-408</ispartof><rights>1994</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</citedby><cites>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0958166994900493$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7765173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leis, Jonathan P</creatorcontrib><creatorcontrib>Cameron, Craig E</creatorcontrib><title>Engineering proteases with altered specificity</title><title>Current opinion in biotechnology</title><addtitle>Curr Opin Biotechnol</addtitle><description>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</description><subject>Aspartic Acid Endopeptidases - genetics</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Bacteria - enzymology</subject><subject>human immunodeficiency virus 1</subject><subject>Models, Molecular</subject><subject>Mutagenesis</subject><subject>Protein Engineering</subject><subject>Retroviridae - enzymology</subject><subject>Rous sarcoma virus</subject><subject>Serine Endopeptidases - genetics</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Substrate Specificity</subject><issn>0958-1669</issn><issn>1879-0429</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPwzAQxy0EKqXwDUDKhGBIOceveEFCVXlIlVhgthznUozSpNgpqN-ehFYdmW74P-7uR8glhSkFKu9AizylUuobzW81ANcpOyJjmiudAs_0MRkfLKfkLMZPABBMwYiMlJKCKjYm03mz9A1i8M0yWYe2QxsxJj---0hs3WHAMolrdL7yznfbc3JS2TrixX5OyPvj_G32nC5en15mD4vUMaa7FDNuyww4VkJJkErw3IHKuSh0UXB0nIqKodRlxquSV2h1hVpRh8yCEpCxCbne9fYnfW0wdmblo8O6tg22m2ioFIoqwXoj3xldaGMMWJl18CsbtoaCGTCZgYEZGBjNzR8mM8Su9v2bYoXlIbTn0uv3Ox37J789BhOdx8Zh6QO6zpSt_3_BL2kkdk0</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>Leis, Jonathan P</creator><creator>Cameron, Craig E</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>1994</creationdate><title>Engineering proteases with altered specificity</title><author>Leis, Jonathan P ; Cameron, Craig E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Aspartic Acid Endopeptidases - genetics</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Bacteria - enzymology</topic><topic>human immunodeficiency virus 1</topic><topic>Models, Molecular</topic><topic>Mutagenesis</topic><topic>Protein Engineering</topic><topic>Retroviridae - enzymology</topic><topic>Rous sarcoma virus</topic><topic>Serine Endopeptidases - genetics</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leis, Jonathan P</creatorcontrib><creatorcontrib>Cameron, Craig E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Current opinion in biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leis, Jonathan P</au><au>Cameron, Craig E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineering proteases with altered specificity</atitle><jtitle>Current opinion in biotechnology</jtitle><addtitle>Curr Opin Biotechnol</addtitle><date>1994</date><risdate>1994</risdate><volume>5</volume><issue>4</issue><spage>403</spage><epage>408</epage><pages>403-408</pages><issn>0958-1669</issn><eissn>1879-0429</eissn><abstract>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>7765173</pmid><doi>10.1016/0958-1669(94)90049-3</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0958-1669
ispartof Current opinion in biotechnology, 1994, Vol.5 (4), p.403-408
issn 0958-1669
1879-0429
language eng
recordid cdi_proquest_miscellaneous_16571753
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aspartic Acid Endopeptidases - genetics
Aspartic Acid Endopeptidases - metabolism
Bacteria - enzymology
human immunodeficiency virus 1
Models, Molecular
Mutagenesis
Protein Engineering
Retroviridae - enzymology
Rous sarcoma virus
Serine Endopeptidases - genetics
Serine Endopeptidases - metabolism
Structure-Activity Relationship
Substrate Specificity
title Engineering proteases with altered specificity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A56%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineering%20proteases%20with%20altered%20specificity&rft.jtitle=Current%20opinion%20in%20biotechnology&rft.au=Leis,%20Jonathan%20P&rft.date=1994&rft.volume=5&rft.issue=4&rft.spage=403&rft.epage=408&rft.pages=403-408&rft.issn=0958-1669&rft.eissn=1879-0429&rft_id=info:doi/10.1016/0958-1669(94)90049-3&rft_dat=%3Cproquest_cross%3E16571753%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16571753&rft_id=info:pmid/7765173&rft_els_id=0958166994900493&rfr_iscdi=true